Registration and Breakfast

WELCOME & INTRODUCTIONS
ARS = Audience Response System

Dr. Paul Lau (Chair)
Scarborough Health Network

“Beyond Biology: Equity, Access, and Outcomes in GI Cancer Care
Includes 7 min Q & A with ARS

Dr. Mojola Omole
Scarborough Health Network

“Beyond AI Scribes: Reimagine your workflow using new AI tools
Includes 7 min Q & A with ARS

Dr. Kyle Fortinsky
Royal Victoria Hospital

KEYNOTE PRESENTATION:
Peritoneal Metastatic Gastric Cancer: Treatment Options
Includes 7 min Q & A with ARS

Dr. Beate Rau
Professor
University Hospital Berlin

BREAK

Tumor Board
Case #1: Hepatocellular Carcinoma
Participants will be asked to use their keypads to choose answers in the two cases.
Participants will be able to ask questions during case discussions

Moderator(s): Dr. Suneil Khanna & Dr. Sheron Perera

Tumor Board
Case #2: NGS in Colon Cancer”

Lunch Breakout

What the Fluke? How the anti-Helminthic do Ivermectin and Fenbendazole Supposedly Treat Cancer
Includes 7 min Q & A with ARS

Mark Pasetka, Pharm D
Pharmacist
Sunnybrook Health Sciences

Improving outcomes for patients with resected colon cancer : The role of a structured exercise program and lowdose aspirin
Includes 7 min Q & A with ARS

Dr. Tim Asmis
Medical Oncologist
Ottawa Hospital

Mindfulness in Oncology: Evidence, Mechanisms, and Practical Applications
Includes 7 min Q & A with ARS

Dr. Punam Rana
Medical Oncologist
Humber River Hospital

BREAK

DEBATE:
In patients with non-metastatic gastric cancer presenting with gastric outlet obstruction, endoscopic intervention be the preferred initial management strategy compared with surgical intervention.

Moderator(s): Dr. Usmaan Hameed

SUMMARY & CLOSING

Paul Lau (Chair)